Vivos (RDGL) 3-1 Month Momentum %: -2.16% (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vivos 3-1 Month Momentum %?

Vivos RDGL +0.48% 3-1 Month Momentum % is -2.16% as of Sep. 06, 2026. The stock has 2 warning signs investors should review. Among 845 Medical Devices & Instruments companies, Vivos ranks better than 64.02% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-06), Vivos's 3-1 Month Momentum % is -2.16%.

The industry rank for Vivos's 3-1 Month Momentum % or its related term are showing as below:

RDGL's 3-1 Month Momentum % is ranked better than
64.02% of 845 companies
in the Medical Devices & Instruments industry
Industry Median: -3.7 vs RDGL: -2.16

Vivos  (OTCPK:RDGL) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Vivos 3-1 Month Momentum % Related Terms

RDGL vs PETV, MODD, GTHP: 3-1 Month Momentum % Comparison

For the Medical Devices subindustry, Vivos's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vivos 3-1 Month Momentum % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vivos's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Vivos's 3-1 Month Momentum % falls into.


Vivos  (OTCPK:RDGL) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -2.16% mean?
Vivos (RDGL) has a 3-1 Month Momentum % of -2.16% as of Sep. 06, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vivos and its competitors. According to the industry distribution chart, Vivos ranks #304 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 36%.
Is Vivos' 3-1 Month Momentum % too high?
Vivos' current 3-1 Month Momentum % is -2.16%. Based on the distribution chart, Vivos ranks #304 out of 845 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Vivos' 3-1 Month Momentum % compare to PETV and MODD?
According to the Medical Devices & Instruments industry distribution chart, Vivos ranks #304 out of 845 companies for 3-1 Month Momentum %. This puts Vivos in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Vivos and its competitors. Vivos's current 3-1 Month Momentum % is -2.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivos stock overvalued right now?
Vivos (RDGL) has a current 3-1 Month Momentum % of -2.16%. The current 3-1 Month Momentum % is -2.16%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Vivos (RDGL), the current 3-1 Month Momentum % is -2.16% as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vivos Business Description

Address 1030 N Center Parkway, Kennewick, WA, USA, 99352
Vivos Inc is a radiation oncology medical device company engaged in the development of its yttrium-90 (Y-90) based precision radionuclide therapy devices. Its portfolio includes RadioGel Precision Radionuclide Therapy (Human Division) for treating solid tumors and positive surgical margins in humans and IsoPet (Animal Division) for treating solid tumors in animals. Vivos also sells PLGA-g-PEG polymers and PrecisionGel, a hydrogel polymer platform for delivering active pharmaceutical ingredients and therapeutic agents. The company currently mainly operates in the United States.